A non-addictive, non-opioid analgesic is on track to become the first newly approved pharmaceutical treatment for fibromyalgia in more than a decade. Last month, Tonix Pharmaceuticals Holding Corp. announced TNX-102 SL, a sublingual version of the common muscle relaxer cyclobenzaprine (brand name: Flexeril), met its primary goal of relieving pain during a randomized, double-blind, placebo-controlled […]

Adastra Pharmaceuticals’ positive results from a Phase Ib trial of its therapy for recurrent high-grade glioblastomas suggest an effective treatment could be available within the next several years. If so, it would be a major breakthrough for patients affected by this lethal disease. The trial evaluated the oral small molecule drug zotiraciclib (ZTR/TG02) in combination […]

As an immigrant, female, mid-30’s CEO in the biotech world, Leen Kawas is used to being told no. She’s familiar with doubts being cast on her ideas, eyebrows raised at her push for innovation and some flat out telling her it won’t work. And she’s comfortable with all of that. It’s that grit that’s gotten […]